2 hrs ago | niagarafallsreview.ca
In Niagara we’re older, fatter, drink more, smoke more and seek out screenings less — and as a result, we’re more likely than anyone else in the province to die of breast or lung cancer five years after diagnosis.
Read more...
cancer Niagara breast survival lung rate Giesbrecht killer provincial Boich region treatment screening
3 hrs ago | eurekalert.org
Researchers from Memorial Sloan-Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung,...
Read more...
squamous squamose lung mutation cancer cell Sloan-Kettering testing tumor SQ-MAP carcinoma genetic non-small cancer-causing
3 hrs ago | dottort.com
Dr. Shane Chapman, MD discusses Skin Metastasis Lung , Colon , Melanoma , Renal . See more at www.dermnet.com PLEASE RATE AND COMMENT!!! LUNG Historically, lung carcinoma is more common in men than women. There is a localized...
Read more...
Dottor T colon melanoma metastasis lung skin cutaneous renal carcinoma nodule metastatic
4 hrs ago | reuters.com
cancers * Was well-tolerated at high doses with minimal toxicity By Bill Berkrot May 16 (Reuters) - A Pfizer Inc lung cancer drug appears to be a highly effective treatment for... In this article: Crizotinib , Lymphoma ,...
Read more...
cancer drug Mosse crizotinib child neuroblastoma ALK study dose rare researcher ALCL patient tumor lymphoma effective toxicity
5 hrs ago | finanznachrichten.de
SAN FRANCISCO, May 17, 2012 /PRNewswire/ --Varian Medical Systems (NYSE: VAR) will showcase radiosurgery technologies for treating early-stage inoperable lung cancer and other conditions non-invasively at the 2012 International...
Read more...
Varian Radiosurgery radiotherapy lung stereotactic Verbakel Radiother Senan Oncol Lagerwaard tumor WF treatment Slotman medical Dec;97
6 hrs ago | streetinsider.com
FREE Breaking News Alerts from StreetInsider.com! CYCC Hot Sheet Overall Analyst Rating: BERKELEY HEIGHTS, N.J., May 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC ) (Nasdaq: CYCCP ) (Cyclacel or the...
Read more...
Cyclacel sapacitabine AML Phase clinical MDS oncology trial DSBs seliciclib patient
6 hrs ago | terradaily.com
Chapel Hill NC (SPX) May 17, 2012 Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many...
Read more...
subtype molecular genetic alteration MD lung cancer therapy PhD mutation response
8 hrs ago | thespec.com
Rhonda Birse Rhonda Birse is a breast cancer survivor. Cathie Coward/The Hamilton Spectator Breast and lung cancer survival rates in Hamilton and surrounding communities are among the worst in the province. The rates for...
Read more...
All similar articles: 69 >>
cancer breast survival chemotherapy Birse radiation colon prostate rate Priamo rectum Hamilton
8 hrs ago | tmcnet.com
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like...
Read more...
MGT Friction BUYINS.NET stock ARSD ROSG CYTK product nu HLF www.buyins.net companys microRNA-based Factor maker
9 hrs ago | me-newswire.net
xml encoding="UTF-8"> ( BUSINESS WIRE )-- Among the numerous abstracts being presented by Boehringer Ingelheim at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2012, the...
Read more...
LUX-Lung afatinib EGFR lung mutation NSCLC Ingelheim Boehringer pivotal cancer study patient ASCO
11 hrs ago | investir.fr
MILAN, ITALY -- (Marketwire) -- 05/17/12 -- MolMed S.p.A. (MILAN: MLM) today announced that six abstracts featuring its investigational therapeutics NGR-hTNF and TK have been accepted for presentation at the 48th ASCO Annual...
Read more...
MolMed NGR-hTNF Phase S.p.A. ASCO abstract 1:15-5:15 mesothelioma TK trial clinical
15 hrs ago | breitbart.com
Atlanta News.Net Wednesday 16th May, 2012 (Source: (Reuters) - Array BioPharma Inc's experimental lung cancer drug, selumetinib, w as shown to increase survival by an additional 4.2 months over chemotherapy alone, according to...
Read more...
lung array cancer selumetinib BioPharma chemotherapy 4.2 w experimental
17 hrs ago | reuters.com
Array BioPharma Inc's experimental lung cancer drug, selumetinib, w as shown to increase survival by an additional 4.2 months over chemotherapy alone, according to new data released on Wednesday. The company also reported...
Read more...
melanoma lung array cancer mutation patient chemotherapy selumetinib NRAS result rise partial survival drug share unconfirmed
18 hrs ago | yahoo.com
Amgen Inc. (AMGN) ’s experimental drug rilotumumab, almost shelved by the company after it disappointed in a study, has been revived after a closer look at data in a gastric cancer trial found it helped a group of patients....
Read more...
Ryan Flinn Amgen patient drug Rilotumumab cancer therapy cure gastric revive tumor medicine MET Chang chemotherapy c-Met abnormality
18 hrs ago | istockanalyst.com
Results Include Data on the Company's Lung Cancer Prognosis Test SALT LAKE CITY, May 16, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today the presentation of a study at the American Society of...
Read more...
Myriad lung Genetics cancer presentation adenocarcinoma clinical disease prognostic CCP study Colaris test patient molecular diagnostic progression ASCO
20 hrs ago | docstoc.com
Exhibit 99.2 NEWS RELEASE LORUS THERAPEUTICS REPORTS THIRD QUARTER RESULTS FOR FISCAL YEAR 2012 TORONTO, ONTARIO – April 12, 2012 – Lorus Therapeutics Inc. (TSX: LOR) (“Lorus” or the “Corporation”) , a biopharmaceutical company...
Read more...
Lorus LOR-253 LOR-220 29 patent February anticancer period promissory 2012 prior compare cancer
23 hrs ago | wallstreet-online.de
SUNNYVALE, California, May 16, 2012 /PRNewswire/ Conference Presentations Highlighted Benefits of the CyberKnife(R) System´s Motion Management and the TomoTherapy(R) System´s Daily Image-Guidance Accuray Incorporated , the...
Read more...
Accuray CyberKnife TomoTherapy treatment System radiation clinical ESTRO Hoogeman SBRT VoLO tumor
May 16, 2012 | wn.com
To: HEALTH AND NATIONAL EDITORS Additional $10.5 million approved in FY2013 Department of Defense Lung Cancer Research Program for 5th Consecutive Year WASHINGTON, May 16, 2012 /PRNewswire-USNewswire/ -- Today, Lung Cancer...
Read more...
All similar articles: 1087 >>
identifiable wn.com cancer email newsletter personally disclose inquiry laxative polyp step clear EDITORS important NATIONAL Privacy collect address Abirateron receive personal cancerous Policy
May 16, 2012 | andhranews.net
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that Novitas, the designated Medicare Administrative Contractor for the Company's miRview®...
Read more...
miRview Rosetta Genomics mets Medicare Novitas assay microRNA-based
May 16, 2012 | nieuwsbank.nl
Woensdag 16 mei 2012 | Roche ] * Trastuzumab emtansine (T-DM1): Pivotal Phase III data (EMILIA) in people with HER2-positive metastatic breast cancer (mBC) who had previously received treatment with Herceptin and a taxane...
Read more...
Avastin emtansine cancer Roche trastuzumab HER2-positive chemotherapy Zelboraf ASCO adv metastatic III Phase colorectal study ovarian BRAF mBC ML18147 treatment
May 16, 2012 | thescottishsun.co.uk
MOTHERS of Scotland, we salute you! Nominate your superhero today Or ‘like’ us at facebook.com/scottishsun . The competition winner will be notified before the event. The prize excludes transport and any additional...
Read more...
Yvonne Bolouri mum Trisha Hannah Mary-Claire Ideal mum-in-a-million Leanne nominate Glasgow
May 16, 2012 | dailymail.co.uk
Daniella Jackson was diagnosed with a tumour in her left lung shortly before discovering she was pregnant She refused doctors' advice to abort her child so they could operate on her When Daniella Jackson was diagnosed with...
Read more...
Paul Bentley Rennae cancer lung unborn Jackson Daniella child birth tumor refuse baby mother doctor abortion Miss diagnose 21 Martin-Ucar disease
May 15, 2012 | vancouversun.com
The reason so many characters smoke in the acclaimed television series, Mad Men , is because it’s set in the 1960′s when smoking was pretty much everyone’s favourite addictive past time. Studies about tobacco hazards were just...
Read more...
Doll lung BC cancer homage Richard doctor smoking research smoker
May 15, 2012 | medicalnewstoday.com
Radiotherapists are constantly battling in order to administer the correct dose of radiotherapy, as respiratory movement during radiotherapy poses a certain risk that a tumor receives either a dose that is insufficient, or the...
Read more...
DIBH tumor radiotherapy Ziouèche patient irradiate motion Boomen 4D scan Bouilhol Gy breathe treatment breathing lung radiation
May 15, 2012 | fortmilltimes.com
IsoRay Inc. (AMEX: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced its financial results for the third fiscal quarter ended March 31, 2012.
Read more...
IsoRay Cesium-131 brachytherapy GliaSite radiation cancer Beriwal radioisotope toxicity
May 15, 2012 | bio-medicine.org
DENVER The most recent research released in June's Journal of Thoracic Oncology says video assisted thoracic surgery (VATS) is a valuable tool in managing lesions detected in a lung cancer screening program. The primary...
Read more...
lung cancer VATS screening thoracic unscreened surgery valuable screened tool 2052 detect CT Danish resection
May 15, 2012 | bio-medicine.org
DENVER The most recent research released in June's Journal of Thoracic Oncology indicates there might be a positive correlation between tumor size and adjuvant platinum based chemotherapy in surgically resected patients with...
Read more...
chemotherapy tumor adjuvant survival size non-small KRAS lung platinum patient effect base cancer mutation node Thoracic II-IIIa
May 15, 2012 | docstoc.com
Aarkstore announce a new report "Cancer Vaccines Markets" through its vast collection of market research report. Aarkstore.com announces, a new market research report is available in its vast collection: Cancer Vaccines Markets...
Read more...
vaccine cancer Aarkstore.com pipeline therapeutic
May 15, 2012 | medicaldesignonline.com
ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today the first successful procedure in the United States with CT-Guide™ navigation. The...
Read more...
ActiViews CT-Guide™ lung navigation procedure cancer Lahey Flacke needle guidance
May 15, 2012 | thisishullandeastriding.co.uk
When Debbie Hunt received a phone call to say she had been nominated for a makeover, it was the perfect end to a good day. That morning, Debbie, 46, travelled to the Queen's Centre at Castle Hill Hospital in Cottingham, where...
Read more...
Debbie Hull all-clear Matalan Colour Lounge hair makeover £8 £4 lung 01482 coral
